Selank

Overview

Selank is a synthetic heptapeptide derived from the naturally occurring human tetrapeptide tuftsin. In laboratory environments, Selank is studied for its potential anxiolytic, nootropic, and immunomodulatory effects in preclinical models such as laboratory rodents. Researchers investigate Selank for its role in modulating neurotransmitter balance, stress response, and immune system pathways.

Benefits

Recent preclinical research suggests that Selank may help reduce anxiety-like behaviors, improve learning and memory markers, and modulate the expression of cytokines and other immune factors in test subjects. Studies indicate that Selank’s mechanism involves regulation of the GABAergic and serotonergic systems, which makes it valuable for research into neurobehavioral and immune processes.
Source: Andreeva LA, et al. Anxiolytic and neuroprotective effects of Selank peptide: preclinical studies. Behavioural Pharmacology, 2018.

Possible Side Effects

In laboratory studies, test subjects administered Selank may exhibit mild side effects such as temporary nasal irritation (when administered intranasally), slight restlessness-like behavior, or subtle changes in appetite-like markers depending on dosage, frequency, and study design.
Source: Andreeva LA, et al., Behavioural Pharmacology, 2018.

Dosage & Administration

Selank is typically administered via intranasal delivery or subcutaneous injection under approved laboratory research protocols. Typical research dosages range from 100 mcg to 500 mcg per administration, delivered once or twice daily depending on the study’s design, test species, and research objectives.
For laboratory research use only. Not for human consumption.

Summary

Selank is a synthetic peptide based on tuftsin, developed exclusively for laboratory research investigating anxiolytic, nootropic, and immunomodulatory pathways in preclinical models. Research suggests it may help reduce anxiety-like markers and modulate immune responses with mild side effects such as nasal irritation occasionally observed in test subjects. Selank is administered intranasally or by subcutaneous injection, with dosage and frequency tailored to each study’s design and species.
Strictly for research purposes only. Not for human use.